scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00109-018-1727-5 |
P698 | PubMed publication ID | 30535867 |
P50 | author | Monica Acosta | Q38799077 |
Ilva D. Rupenthal | Q54195935 | ||
Jie Zhang | Q59544796 | ||
Odunayo O Mugisho | Q90285258 | ||
Sarah J Bould | Q114291013 | ||
P2093 | author name string | Helen V Danesh-Meyer | |
Colin R Green | |||
David M Squirrell | |||
P2860 | cites work | Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results | Q24633874 |
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. | Q28583917 | ||
Thioredoxin-interacting protein links oxidative stress to inflammasome activation | Q29614471 | ||
Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. | Q30356505 | ||
Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy | Q34426246 | ||
Connexin and pannexin signaling pathways, an architectural blueprint for CNS physiology and pathology? | Q34482628 | ||
Risk of geographic atrophy in the comparison of age-related macular degeneration treatments trials | Q35003936 | ||
ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels | Q35024390 | ||
Macular edema. A complication of diabetic retinopathy | Q36601960 | ||
Connexin and pannexin hemichannels in inflammatory responses of glia and neurons | Q36769898 | ||
Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy | Q36952309 | ||
Inflammation in diabetic retinopathy | Q37884176 | ||
A key role for connexin hemichannels in spreading ischemic brain injury | Q38061437 | ||
The NLRP3 Inflammasome and its Role in Age-Related Macular Degeneration | Q38596848 | ||
Connexin43 in retinal injury and disease | Q38598207 | ||
Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability | Q38617017 | ||
NLRP3 Is Involved in Ischemia/Reperfusion Injury | Q38782148 | ||
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway | Q38796322 | ||
Connexins and their channels in inflammation | Q38888995 | ||
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents | Q38975099 | ||
Connexin43 Mimetic Peptide Improves Retinal Function and Reduces Inflammation in a Light-Damaged Albino Rat Model | Q39525664 | ||
Role of inflammation in the pathogenesis of diabetic retinopathy | Q41012127 | ||
Selective inhibition of Cx43 hemichannels by Gap19 and its impact on myocardial ischemia/reperfusion injury. | Q41131251 | ||
Connexin hemichannel blockade improves outcomes in a model of fetal ischemia | Q42633519 | ||
Acute downregulation of connexin43 at wound sites leads to a reduced inflammatory response, enhanced keratinocyte proliferation and wound fibroblast migration. | Q42832944 | ||
A flow cytometric analysis of vitreous inflammatory cells in patients with proliferative diabetic retinopathy | Q42911116 | ||
Immunolocalization of gap junction protein connexin43 (GJA1) in the human retina and optic nerve. | Q43106752 | ||
Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. | Q46467494 | ||
Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. | Q46774822 | ||
Cytokines in the vitreous of patients with proliferative diabetic retinopathy | Q46851731 | ||
Immunohistochemical Characterization of Connexin43 Expression in a Mouse Model of Diabetic Retinopathy and in Human Donor Retinas | Q47176174 | ||
Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications | Q47770967 | ||
NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy. | Q48151440 | ||
Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia | Q48416361 | ||
Characterizing the mode of action of extracellular Connexin43 channel blocking mimetic peptides in an in vitro ischemia injury model. | Q48438781 | ||
Systemic Administration of Connexin43 Mimetic Peptide Improves Functional Recovery after Traumatic Spinal Cord Injury in Adult Rats | Q48512809 | ||
The inflammasome pathway is amplified and perpetuated in an autocrine manner through connexin43 hemichannel mediated ATP release | Q48595218 | ||
Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia | Q48654177 | ||
The NLRP3 Inflammasome May Contribute to Pathologic Neovascularization in the Advanced Stages of Diabetic Retinopathy. | Q49169179 | ||
Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances neuroprotection after retinal ischemia. | Q50250404 | ||
Connexin43 mimetic peptide is neuroprotective and improves function following spinal cord injury. | Q50484003 | ||
Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds. | Q50493571 | ||
Glial reactivity, an early feature of diabetic retinopathy. | Q50511477 | ||
Targeting connexin43 expression accelerates the rate of wound repair. | Q52099637 | ||
Higher Numbers of Hyperreflective Foci Seen in the Vitreous on Spectral-Domain Optical Coherence Tomographic Images in Eyes with More Severe Diabetic Retinopathy. | Q52871340 | ||
Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy | Q58723006 | ||
Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy | Q83625730 | ||
P433 | issue | 2 | |
P921 | main subject | diabetic retinopathy | Q631361 |
P304 | page(s) | 215-229 | |
P577 | publication date | 2018-12-08 | |
P1433 | published in | Journal of Molecular Medicine | Q6295593 |
P1476 | title | Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease | |
P478 | volume | 97 |
Search more.